Cargando…

Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis

BACKGROUND: Takayasu arteritis (TA) is a rare disease, lacking convenient and feasible biomarkers to identify disease activity. We aimed to evaluate the value of complements in distinguishing active TA. METHODS: Consecutive patients were enrolled from the prospective East China TA cohort from April...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Rongyi, Ma, Lingying, Lv, Peng, Lin, Jiang, Li, Chaolun, Yan, Yan, Jin, Xuejuan, Dai, Xiaomin, Ji, Zongfei, Chen, Huiyong, Ma, Lili, Sun, Ying, Jiang, Lindi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903686/ https://www.ncbi.nlm.nih.gov/pubmed/33627173 http://dx.doi.org/10.1186/s13075-021-02433-x

Ejemplares similares

Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
por: Ying, Sun, et al.
Publicado: (2020)

Serum leptin, a potential predictor of long‐term angiographic progression in Takayasu’s arteritis
por: Ma, Lili, et al.
Publicado: (2019)

Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China
por: Kong, Xiufang, et al.
Publicado: (2020)

A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis
por: Kong, Xiufang, et al.
Publicado: (2022)

Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
por: Wu, Chunling, et al.
Publicado: (2020)

Risk factors of aortic regurgitation progression in Chinese patients with Takayasu’s arteritis: a prospective cohort study
por: Wang, Yujiao, et al.
Publicado: (2022)

Biomarker Changes and Molecular Signatures Associated with Takayasu Arteritis Following Treatment with Glucocorticoids and Tofacitinib
por: Dai, Xiaojuan, et al.
Publicado: (2022)

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension
por: Ying, Sun, et al.
Publicado: (2021)

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study
por: Rongyi, Chen, et al.
Publicado: (2023)

Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
por: Kong, Xiufang, et al.
Publicado: (2021)

In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease
por: Zongfei, Ji, et al.
Publicado: (2020)

Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020)

Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)
por: Sun, Ying, et al.
Publicado: (2023)

COVID-19 vaccine uptake, hesitancy and clinical effects on patients with Takayasu’s arteritis: A web-based questionnaire survey from a large cohort
por: Kong, Xiufang, et al.
Publicado: (2023)

Clinical and pathological predictors of relapse in IgG4-related disease
por: Zongfei, Ji, et al.
Publicado: (2022)

Augmented PFKFB3-mediated glycolysis by interferon-γ promotes inflammatory M1 polarization through the JAK2/STAT1 pathway in local vascular inflammation in Takayasu arteritis
por: Chen, Rongyi, et al.
Publicado: (2022)

Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry
por: Zongfei, Ji, et al.
Publicado: (2021)

Echocardiographic characteristics of pulmonary artery involvement in Takayasu arteritis
por: Jiang, Wei, et al.
Publicado: (2017)

Takayasu Arteritis
por: Russo, Ricardo A. G., et al.
Publicado: (2018)

Serum cytokines in childhood-Takayasu arteritis: Are they biomarkers for indolent disease activity?()
por: Clemente, Gleice, et al.
Publicado: (2023)

Advancements in medical and surgical treatments of Takayasu arteritis-induced renal arteritis: a systematic review
por: Dai, Xiao-Min, et al.
Publicado: (2020)

Takayasu arteritis in children
por: Al abrawi, Safia, et al.
Publicado: (2008)

Takayasu's arteritis in childhood
por: Brunner, J
Publicado: (2008)

Takayasu arteritis in an infant
por: Sandeep, S., et al.
Publicado: (2014)

Scleritis in Takayasu Arteritis
por: Chittipolu, Swetha, et al.
Publicado: (2023)

Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm
por: Pan, Lili, et al.
Publicado: (2019)

Takayasu Arteritis Coexisting with Cutaneous Leishmaniasis
por: Zhao, Mutong, et al.
Publicado: (2023)

Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis
por: Misra, Durga Prasanna, et al.
Publicado: (2022)

Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022)

Surgical Management of Takayasu's Arteritis
por: Joh, Jin-Hyun, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

Bentall procedure in Takayasu arteritis
por: Hidiroglu, M, et al.
Publicado: (2013)

Recurrent Vertigo: Is it Takayasu's Arteritis?
por: Ashutosh, Tiwari, et al.
Publicado: (2013)

5. Paediatric Takayasu arteritis
por: Mackay, Madeleine, et al.
Publicado: (2018)

“Macaroni Sign” in Takayasu Arteritis
por: Ghembaza, Mohammed El Amine, et al.
Publicado: (2018)

Intracranial Involvement in Takayasu’s Arteritis
por: Johnson, Andrea, et al.
Publicado: (2021)

Novel Therapies in Takayasu Arteritis
por: Regola, Francesca, et al.
Publicado: (2022)

Takayasu Arteritis Mimicking Phlegmon
por: Taira, Yuki, et al.
Publicado: (2022)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Altered glycosylation profiles of serum IgG in Takayasu arteritis
por: Liu, Lingyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_onl6nj9do0ic4r4jlg907o3nub